Volitionrx Ltd (VNRX) Stock Price, Quote & News

Company Profile

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progre...

Industry: Medical Devices

Sector: Healthcare

Phone: 646 650 1351

Website: volition.com

Address:

1489 West Warm Springs Road, Suite 110, Henderson, United States

NetworkNewsWire Jan. 30 at 6:42 PM

BioMedNewsBreaks — $VNRX Prepares Reimbursement Submission for Nu.Q Cancer Assays in France https://ibn.fm/qxNIy

0 · Reply

2021er Jan. 30 at 6:10 PM

$VNRX

0 · Reply

KelsoWins Jan. 30 at 6:09 PM

$VNRX LFG Cats!

0 · Reply

Rpembo Jan. 30 at 5:21 PM

$VNRX $RPGL $VISL Bulls running wild!

0 · Reply

2021er Jan. 30 at 4:08 PM

$VNRX i remember last june as it broke the 50d MA it shot up to 200d MA and above..this time could or should be sustainible🫠🙏🤗

1 · Reply

Glencore Jan. 29 at 7:02 PM

$VNRX If anyone has any brains they should buy out the company before the reverse split ,1 and a half dollars/share should do the trick.

1 · Reply

Kululu Jan. 29 at 5:47 PM

$VNRX other stocks strategize other moves like cryptocurrency pivot or insiders massiive buying to drive up the price. These id iota do nothing but dilute more. Did you see their insider purchase history? Only that dimwit ceo makes some purchases but a very few. Other directors and executive management are just a bunch of conniving bastards

0 · Reply

Kululu Jan. 29 at 2:50 PM

$VNRX yes this one will slowly bleed to under ten cents

1 · Reply

Bigspydee040 Jan. 28 at 3:24 PM

$VNRX - the recent proposal means there is not going to be a deal till March end 2026. F**k Cameron Reynolds.

1 · Reply

Kululu Jan. 28 at 2:53 PM

$VNRX this crooked cleft lip ceo lies through his mouth all the time. Mitherfucker wants more dilution. That’s why doing a rs. So they will allocate 20% more share to a company by diluting the existsing shareholders at the same time will do a reverse split to consolidate. That means shareholders gets screwed on both ways.

0 · Reply

VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays

Jan 27, 2026, 8:00 AM EST - 3 days ago

Volition Announces Data to Support Use of Nu.Q® NETs in New Indication

Jan 20, 2026, 8:25 AM EST - 10 days ago

Volition Continues to Extend Access to Nu.Q® Vet Cancer Test

Jan 16, 2026, 8:45 AM EST - 14 days ago

Volition Sponsors Symposium at Veterinary Meeting and Expo

Jan 8, 2026, 9:15 AM EST - 22 days ago

VolitionRx Secures $2.0 Million in Funding

Jan 8, 2026, 8:45 AM EST - 22 days ago

VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats

Dec 17, 2025, 8:45 AM EST - 6 weeks ago

Volition Issues Business Review 2025

Dec 11, 2025, 9:00 AM EST - 7 weeks ago

Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment

Dec 8, 2025, 9:00 AM EST - 7 weeks ago

Volition Announces Two Abstracts were Presented at the North America Conference on Lung Cancer

Dec 4, 2025, 9:00 AM EST - 2 months ago

VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis

Nov 25, 2025, 8:45 AM EST - 2 months ago

VolitionRx Limited Announces the First Sale of the Nu.Q® Cancer Assays for Clinical Certification in Preparation for Routine Clinical Use

Nov 14, 2025, 12:51 PM EST - 2 months ago

VolitionRx Limited (VNRX) Q3 2025 Earnings Call Transcript

Nov 13, 2025, 4:10 PM EST - 2 months ago

VolitionRx Limited Announces Third Quarter 2025 Financial Results and Business Update

Nov 10, 2025, 8:45 AM EST - 2 months ago

VolitionRx Limited Schedules Third Quarter 2025 Earnings Conference Call and Business Update

Oct 17, 2025, 8:00 AM EDT - 3 months ago

Volition Donates Nu.Q® Vet Cancer Tests to HOPE Animal-Assisted Crisis Response Dogs

Oct 10, 2025, 8:30 AM EDT - 4 months ago

VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants

Oct 9, 2025, 4:05 PM EDT - 4 months ago

VolitionRx Limited Announces Proposed Underwritten Public Offering of Common Stock and Common Stock Warrants

Oct 8, 2025, 4:56 PM EDT - 4 months ago

VolitionRx Limited - Special Call

Oct 2, 2025, 8:45 AM EDT - 4 months ago

Volition Sponsors Upcoming GenomeWeb Webinar

Sep 29, 2025, 9:30 AM EDT - 4 months ago

Volition Signs Co-Marketing and Services Agreement with Hologic

HOLX

Sep 9, 2025, 8:45 AM EDT - 5 months ago

Volition Signs First Human Out Licensing Deal

Aug 15, 2025, 2:24 PM EDT - 6 months ago

VolitionRx Limited (VNRX) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 4:10 PM EDT - 6 months ago

VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update

Aug 8, 2025, 8:30 AM EDT - 6 months ago

VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update

Aug 4, 2025, 4:01 PM EDT - 6 months ago

VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering

Jul 16, 2025, 8:00 AM EDT - 7 months ago

Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation

Jul 8, 2025, 8:00 AM EDT - 7 months ago

Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes

Jun 12, 2025, 8:30 AM EDT - 8 months ago

Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure

Jun 4, 2025, 9:00 PM EDT - 8 months ago

Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties

May 19, 2025, 8:30 AM EDT - 9 months ago

VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats

May 16, 2025, 7:19 PM EDT - 9 months ago

VolitionRX Limited (VNRX) Q1 2025 Earnings Call Transcript

May 15, 2025, 5:37 PM EDT - 9 months ago

VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update

May 12, 2025, 8:30 AM EDT - 9 months ago

VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update

May 7, 2025, 8:30 AM EDT - 9 months ago

VolitionRX Limited: Outlines broad strategy to become the 'NETs company' worldwide through licensing and updates progress of Nu.Q® NETs test adoption

Apr 29, 2025, 8:30 AM EDT - 9 months ago

VolitionRX Limited: Revolutionizing the diagnosis and monitoring of life-altering diseases for both humans and animals in multi-billion dollar markets

Apr 1, 2025, 12:31 AM EDT - 10 months ago

VolitionRx Limited (VNRX) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 4:05 PM EDT - 10 months ago

VolitionRx Limited Announces Full Fiscal Year 2024 Financial Results and Business Update

Mar 28, 2025, 8:00 AM EDT - 11 months ago

Volition Announces Two Poster Presentations at ESMO's European Lung Cancer Congress 2025

Mar 27, 2025, 8:30 AM EDT - 11 months ago

Volition to Host Virtual Investor Event on Nu.Q® Cancer, "A Look to the Future of Cancer Diagnostics", on April 9, 2025

Mar 26, 2025, 8:00 AM EDT - 11 months ago

VolitionRx Announces Pricing of up to $2.3 Million Registered Direct Offering

Mar 25, 2025, 9:30 AM EDT - 11 months ago

VolitionRx Limited Schedules Full Fiscal Year 2024 Earnings Conference Call and Business Update

Mar 21, 2025, 8:30 AM EDT - 11 months ago

Volition's Nu.Q® Cancer Diagnostics Test Aims To Disrupt the Multi-Billion Dollar Liquid Biopsy Industry

Mar 20, 2025, 8:30 AM EDT - 11 months ago

Volition Introduces Nu.Q® Cancer Blood Test in New Industry Primer for Lung Cancer

Mar 17, 2025, 8:30 AM EDT - 11 months ago

Volition Proudly Sponsors the 44th ISICEM Congress

Mar 13, 2025, 8:30 AM EDT - 11 months ago

Volition Signs first ever Nu.Q® Vet Cancer Test Automation Agreement with Fujifilm Vet Systems

Mar 11, 2025, 8:30 AM EDT - 11 months ago

Volition Announces First Patient Enrolled in NTU Hospital's Prospective Validation Study of Nu.Q® Lung Cancer Test

Mar 4, 2025, 8:30 AM EST - 11 months ago

Volition's Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time

Feb 28, 2025, 8:30 AM EST - 1 year ago

Volition Showcases Nu.Q® Vet Cancer Test at the 97th WVC Annual Conference

Feb 6, 2025, 8:30 AM EST - 1 year ago

Volition Signs First Commercial Project Utilizing Rapid High-Throughput Model in the Study of NETosis

Feb 5, 2025, 9:15 AM EST - 1 year ago

Volition to Host Virtual Investor Event on Nu.Q® NETs, "Casting a New Light on Sepsis Management", on February 14, 2025

NetworkNewsWire Jan. 30 at 6:42 PM

BioMedNewsBreaks — $VNRX Prepares Reimbursement Submission for Nu.Q Cancer Assays in France https://ibn.fm/qxNIy

0 · Reply

2021er Jan. 30 at 6:10 PM

$VNRX

0 · Reply

KelsoWins Jan. 30 at 6:09 PM

$VNRX LFG Cats!

0 · Reply

Rpembo Jan. 30 at 5:21 PM

$VNRX $RPGL $VISL Bulls running wild!

0 · Reply

2021er Jan. 30 at 4:08 PM

$VNRX i remember last june as it broke the 50d MA it shot up to 200d MA and above..this time could or should be sustainible🫠🙏🤗

1 · Reply

Glencore Jan. 29 at 7:02 PM

$VNRX If anyone has any brains they should buy out the company before the reverse split ,1 and a half dollars/share should do the trick.

1 · Reply

Kululu Jan. 29 at 5:47 PM

0 · Reply

Kululu Jan. 29 at 2:50 PM

$VNRX yes this one will slowly bleed to under ten cents

1 · Reply

Bigspydee040 Jan. 28 at 3:24 PM

$VNRX - the recent proposal means there is not going to be a deal till March end 2026. F**k Cameron Reynolds.

1 · Reply

Kululu Jan. 28 at 2:53 PM

0 · Reply

2021er Jan. 28 at 2:17 PM

$VNRX

1 · Reply

peepthestamp Jan. 28 at 1:06 PM

$VNRX

0 · Reply

moemog Jan. 28 at 12:19 PM

$VNRX today is the day 🚀 Mark this post. MoG

1 · Reply

jetty323 Jan. 27 at 2:02 PM

$VNRX well golly gee. most likely a 10:1 at minimum, anything less than that and they'll drive the stock back under $1 in no time.

0 · Reply

Bigspydee040 Jan. 27 at 4:31 AM

$VNRX - https://ir.stockpr.com/volition/sec-filings-email/content/0001477932-26-000396/vnrx_pre14a.htm

0 · Reply

moemog Jan. 25 at 4:02 PM

$VNRX ☕ 👉🏼⏰👈🏼 MoG

0 · Reply

Kululu Jan. 23 at 4:45 PM

$VNRX can’t we have a good day for god sake? We never go up like other stocks

1 · Reply

2021er Jan. 22 at 6:58 PM

$VNRX just a matter of time and patience..the company grows, sp will folllow

0 · Reply

Kululu Jan. 22 at 4:21 PM

$VNRX they diluted the stock so much that it goes down even the company have good news

0 · Reply

Kululu Jan. 21 at 3:37 PM

$VNRX people don’t realize management team are involved in market manipulation. They have to ru their company by selling shares and dilution. All these news that we are seeing do nothing to revenue process. This company raised money 7 times in last 12 months.

0 · Reply

braining1 Jan. 21 at 8:35 AM

$VNRX Good Update from this Twitter Post... https://x.com/i/status/2013826027659919703

0 · Reply

2021er Jan. 21 at 8:33 AM

$VNRX

0 · Reply

Market Cap	30.84M
Revenue (ttm)	1.23M
Net Income (ttm)	-26.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,192.68%
Debt to Equity Ratio	-0.22

Volume	6,623,800
Avg Vol	2,704,284
Day's Range	N/A - N/A
Shares Out	122.80M
Stochastic %K	35%
Beta	1.23
Analysts	Strong Sell
Price Target	$2.20